Maslanka v. Johnson & Johnson, Inc.

305 F. App'x 848
CourtCourt of Appeals for the Third Circuit
DecidedDecember 23, 2008
Docket08-2329
StatusUnpublished
Cited by10 cases

This text of 305 F. App'x 848 (Maslanka v. Johnson & Johnson, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Maslanka v. Johnson & Johnson, Inc., 305 F. App'x 848 (3d Cir. 2008).

Opinion

OPINION

PER CURIAM.

Timothy W. Maslanka appeals from the order of the United States District Court for the District of New Jersey granting summary judgment on his discrimination claims brought pursuant to the Americans with Disabilities Act (“ADA”), 42 U.S.C. § 12101 et seq. (1990).

I.

Timothy Maslanka was employed as a sales representative at Janssen Pharmaceutical Company from June 26, 2000, until his termination almost two years later, effective May 30, 2002. His supervisor for the entire two-year period was Robert Fronius. Maslanka received two positive initial evaluations from Fronius. Things began to change in February 2001, however, as Fronius’s evaluations became more and more negative. On April 16 or 17, *850 2001, Fronius gave Maslanka a very harsh evaluation, which led to a formal warning letter from Fronius, dated April 23, 2001. On the same day he received the formal warning letter, Maslanka filed a complaint with the Equal Employment Opportunity Commission (“EEOC”), complaining that he was being harassed by Fronius on account of his age (Maslanka was considerably older than Fronius). He checked off “retaliation” on the EEOC complaint, but included no explanation. Although he mentioned many work-related reasons why Fronius might be motivated to discriminate against him, none of them was disability-based (or age-based).

Maslanka’s efforts to be assigned to a different supervisor failed. In June 2001, he was placed on temporary disability leave for a knee injury. His general practitioner, Dr. Reilly, noted, however, that Maslanka was also suffering from significant anxiety disorder and major depression associated with his stressful work situation. Another physician, Dr. Mehta, who treated Maslanka during the same time period, came to the same diagnosis. Maslanka remained out on sick leave until Doctor Mehta cleared him to return to his employment at Janssen “without restriction” on December 1, 2001. Addressing Maslanka’s anxiety/depression, Drs. Reilly and Mehta recommended that he work under a different supervisor or in a different department. Janssen provided Maslanka with a minivan for his knee injury, but it did not change his job or his supervisor. On Maslanka’s return from sick leave, Fronius told him that he did not care about Maslanka’s disability and that if his sales numbers did not get better, Maslanka was not going to remain employed at Janssen for long. From Maslanka’s point of view, Fronius’s negative evaluations from December 2001 on were completely unfounded. Maslanka submitted glowing informal evaluations from his clients about a seminar he organized in December 2001, as well as data showing that he was doing as well as, if not better than, his colleagues.

In January or February 2002, Maslanka filed a claim against Fronius pursuant to Janssen’s alternate dispute resolution program. Thereafter, Maslanka and Fronius had minimal contact. In mid-April 2002, Janssen announced a roundtable discussion of physicians regarding its drug, Duragesic, which was scheduled to occur on April 26. Janssen asked Maslanka to send an invitation to one of his clients, Dr. Hess. In accordance with Janssen’s Healthcare Compliance Guidelines and policy, which Maslanka admits he knew, the invitation informed the doctor that he would be financially responsible for his spouse’s airline ticket, and for meals and activities not covered by the seminar. Hess accepted the invitation and, owing to the lack of time, Maslanka offered to arrange travel for Hess and his wife using his corporate credit card. Maslanka never “expensed” the cost of the ticket for Hess’s wife. The understanding was that Hess would pay him back. In late May 2002, Fronius called Maslanka, demanding that he come to a meeting the next day. Maslanka did not attend the meeting because he had a panic attack, which required attention in the emergency room. Dr. Mehta placed him on a leave of absence on May 29, 2002, “for at least four days.” On June 3, 2002, he wrote that Maslanka was “unable to return to work until further notice.”

In a letter dated June 14, 2002, Janssen terminated Maslanka’s employment, effective May 30, 2002, because he violated its healthcare compliance policy by paying for Mrs. Hess’s travel tickets with his corporate American Express card. In September 2002, Maslanka filed another complaint with the EEOC, alleging that he became disabled because of Fronius’s continued *851 harassment and that Janssen discriminated against him on account of his disability by terminating his employment.

In 2003, after exhausting his administrative remedies, Maslanka filed a complaint against Janssen and its parent company, Johnson & Johnson (the “defendants”), in United States District Court for the Middle District of Florida; the matter was transferred to the District of New Jersey. Maslanka alleged that he was disabled by generalized anxiety and depression, which substantially limited the major life activities of sleeping, concentrating, and working. He claimed that Janssen discriminated against him on account of his disability when it effectively terminated his employment in May 2002, and retaliated against him for filing an EEOC complaint and a complaint against Fronius with Janssen’s alternate dispute resolution program. He sought damages.

After a period of contentious discovery, which closed in October 2006, the defendants moved for summary judgment. They contended that Maslanka was not disabled under the ADA because he failed to provide sufficient evidence that he was impaired by anxiety and/or depression and because the alleged impairment was temporary and did not substantially limit a major life activity. Moreover, the defendants claimed that Maslanka was terminated for a legitimate non-discriminatory reason — his violation of company policy — and thus, Maslanka’s ADA, hostile environment, and retaliation claims lacked merit.

Maslanka responded, contending that the defendant’s proffered reason for terminating him was pretextual. He disputed the defendants’ assertion that the company’s invitation for the roundtable discussion was consistent with its policy on health care compliance. He submitted his own affidavit and one from Dr. Hess, attesting that Maslanka never promised to pay for his wife’s ticket and that it was understood that Dr. Hess would reimburse Maslanka for it. Maslanka also attested that he never “expensed” the cost of Mrs. Hess’s travel to the company. He asserted that there was a genuine dispute of material fact with respect to whether he violated company policy. He also requested that discovery be reopened so that the defendants could answer outstanding discovery requests made before the discovery period had closed. He claimed that the defendants retaliated against him by thwarting his attempts to obtain employment after he was fired.

The District Court granted summary judgment in the defendants’ favor on all claims. The District Court denied Maslanka’s request to reopen discovery. It dismissed all claims as to Johnson & Johnson because Maslanka failed to allege its involvement in any discriminatory activity or retaliation.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

MOSES v. WAYFAIR INC.
D. New Jersey, 2024
Thomas v. Wetzel
M.D. Pennsylvania, 2024
Brown v. LT. MAXWELL
M.D. Pennsylvania, 2022
Nunez v. Wolf
M.D. Pennsylvania, 2022
Cramer v. Kerestes
M.D. Pennsylvania, 2020
Staple v. Horener
M.D. Pennsylvania, 2020
Naber v. Dover Healthcare Associates, Inc.
765 F. Supp. 2d 622 (D. Delaware, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
305 F. App'x 848, Counsel Stack Legal Research, https://law.counselstack.com/opinion/maslanka-v-johnson-johnson-inc-ca3-2008.